Tyr846

Javascript is not enabled on this browser. This site will not work properly without Javascript.

Home > Phosphorylation Site Page: > Tyr846 - ENPP2 (human)

Site Information
FRKTSRSyPEILTLK SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 472751

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 )
Disease tissue studied:	leukemia ( 1 ) , acute lymphocytic leukemia ( 1 )
Relevant cell line - cell type - tissue:	SEM (B lymphocyte) ( 1 )

References
1	Moritz A (2006) CST Curation Set: 1820; Year: 2006; Biosample/Treatment: cell line, SEM/Flt3 inhibitor; Disease: acute lymphocytic leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991 Curated Info

References

1

Moritz A (2006) CST Curation Set: 1820; Year: 2006; Biosample/Treatment: cell line, SEM/Flt3 inhibitor; Disease: acute lymphocytic leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

PhosphoSitePlus^® is a registered trademark of Cell Signaling Technology.
Use of PSP data is subject to a formal license agreement. Learn more